Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 24 , ISSUE 8 ( August, 2020 ) > List of Articles


Vitamin C Therapy for Routine Care in Septic Shock (ViCTOR) Trial: Effect of Intravenous Vitamin C, Thiamine, and Hydrocortisone Administration on Inpatient Mortality among Patients with Septic Shock

Zubair U Mohamed, Pratibha Prasannan, Merlin Moni, Fabia Edathadathil, Preetha Prasanna, Anup Menon, Sabarish Nair, CR Greeshma, Dipu T Sathyapalan, Veena Menon, Vidya Menon

Citation Information : Mohamed ZU, Prasannan P, Moni M, Edathadathil F, Prasanna P, Menon A, Nair S, Greeshma C, Sathyapalan DT, Menon V, Menon V. Vitamin C Therapy for Routine Care in Septic Shock (ViCTOR) Trial: Effect of Intravenous Vitamin C, Thiamine, and Hydrocortisone Administration on Inpatient Mortality among Patients with Septic Shock. Indian J Crit Care Med 2020; 24 (8):653-661.

DOI: 10.5005/jp-journals-10071-23517

License: CC BY-NC 4.0

Published Online: 21-09-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Background: Sepsis remains a leading cause of death worldwide despite advances in management strategies. Preclinical and observational studies have found mortality benefit with high-dose vitamin C in sepsis. Our study aims to prospectively evaluate the effect of intravenous hydrocortisone, vitamin C [ascorbic acid (AA)], and thiamine (HAT) administration in reducing inpatient all-cause mortality among patients with septic shock. Materials and methods: Our single-center, prospective, open-label, randomized controlled trial recruited patients with admitting diagnosis of septic shock and assigned eligible patients (1:1) into either intervention (HAT) or control group (routine). The HAT group received intravenous combination of vitamin C (1.5 g every 6 hours), thiamine (200 mg every 12 hours), and hydrocortisone (50 mg every 6 hours) within 6 hours of onset of septic shock admission. The treatment was continued for at least 4 days, in addition to the routine standard of care provided to the control group. Thiamine and hydrocortisone use in control arm was not restricted. Vitamin C levels were estimated at baseline and at the end of the 4 days of treatment for both groups. The primary outcome evaluated was mortality during inpatient stay. Results: Among 90 patients enrolled, 88 patients completed the study protocol. The baseline characteristics between the HAT (n = 45) and the routine (n = 43) groups were comparable. The all-cause mortality in the HAT cohort was 57% (26/45) compared to 53% (23/43) in the routine care group (p = 0.4, OR 1.19, 95% CI 0.51–2.76). The time to reversal of septic shock was significantly lower in the HAT (34.58 ± 22.63 hours) in comparison to the routine care (45.42 ± 24.4 hours) (p = 0.03, mean difference −10.84, 95% CI −20.8 to −0.87). No significant difference was observed between the HAT and the routine care with respect to changes in sequential organ failure assessment (SOFA) scores at 72 hours (2.23 ± 2.4 vs 1.38 ± 3.1), the use of mechanical ventilation (48% vs 46%), and mean Vasoactive Inotropic Score (7.77 ± 12.12 vs 8.86 ± 12.5). Conclusion: Intravenous administration of vitamin C, thiamine, and hydrocortisone did not significantly improve the inpatient all-cause mortality among patients with septic shock. Clinical significance: HAT protocol does not reduce hospital mortality but decreases time to shock reversal in septic shock.

  1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016;315(8):801. DOI: 10.1001/jama.2016.0287.
  2. Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am J Respir Crit Care Med 2016;193(3):259–272. DOI: 10.1164/rccm.201504-0781OC.
  3. Teng J, Pourmand A, Mazer-Amirshahi M. Vitamin C: the next step in sepsis management? J Crit Care 2018;43:230–234. DOI: 10.1016/j.jcrc.2017.09.031.
  4. Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014;311(13):1308. DOI: 10.1001/jama.2014.2637.
  5. Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettilä V. Long-term outcome and quality-adjusted life years after severe sepsis*. Crit Care Med 2009;37(4):1268–1274. DOI: 10.1097/CCM.0b013e31819c13ac.
  6. Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J-L. Sepsis and septic shock. Nat Rev Dis Prim 2016;2(1):16045. DOI: 10.1038/nrdp.2016.45.
  7. Belsky JB, Wira CR, Jacob V, Sather JE, Lee PJ. A review of micronutrients in sepsis: the role of thiamine, l-carnitine, vitamin C, selenium and vitamin D. Nutr Res Rev 2018;31(2):281–290. DOI: 10.1017/S0954422418000124.
  8. Fowler AA, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014;12(1):32. DOI: 10.1186/1479-5876-12-32.
  9. Tanaka H. Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration. Arch Surg 2000;135(3):326. DOI: 10.1001/archsurg.135.3.326.
  10. Woolum JA, Abner EL, Kelly A, Thompson Bastin ML, Morris PE, Flannery AH. Effect of thiamine administration on lactate clearance and mortality in patients with septic shock*. Crit Care Med 2018;46(11):1747–1752. DOI: 10.1097/CCM.0000000000003311.
  11. Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med 2018;378(9):797–808. DOI: 10.1056/NEJMoa1705835.
  12. Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis. Chest 2020;158(1):164–173. DOI: 10.1016/j.chest.2020.02.049.
  13. Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock. JAMA 2020;323(5):423. DOI: 10.1001/jama.2019.22176.
  14. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017;43(3):304–377. DOI: 10.1007/s00134-017-4683-6.
  15. Machado MN, Nakazone MA, Maia LN. Acute kidney injury based on KDIGO (kidney disease improving global outcomes) criteria in patients with elevated baseline serum creatinine undergoing cardiac surgery. Rev Bras Cir Cardiovasc 2014;29(3):299–307. DOI: 10.5935/1678-9741.20140049.
  16. Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, et al. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery. Pediatr Crit Care Med 2014;15(6):529–537. DOI: 10.1097/PCC.0000000000000153.
  17. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003;109(2):144–148. DOI: 10.1016/S0022-4804(02)00083-5.
  18. Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock. Chest 2017;151(6):1229–1238. DOI: 10.1016/j.chest.2016.11.036.
  19. Kahan BC, Jairath V, Doré CJ, Morris TP. The risks and rewards of covariate adjustment in randomized trials: an assessment of 12 outcomes from 8 studies. Trials 2014;15(1):139. DOI: 10.1186/1745-6215-15-139.
  20. Wani SJ, Mufti SA, Jan RA, Shah S, Qadri SM, Khan UH, et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis (Auckl) 2020;52(4):271–278. DOI: 10.1080/23744235.2020.1718200.
  21. Chang P, Liao Y, Guan J, Guo Y, Zhao M, Hu J, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock (HYVCTTSSS): a randomized controlled clinical trial. Chest 2020;158(1):174–182. DOI: 10.1016/j.chest.2020.02.065.
  22. Chatterjee S, Bhattacharya M, Todi S. Epidemiology of adult-population sepsis in india: a single center 5 year experience. Indian J Crit Care Med 2017;21(9):573–577. DOI: 10.4103/ijccm.IJCCM_240_17.
  23. Yeh C-C, Chen Y-A, Hsu C-C, Chen JH, Chen WL, Huang CC, et al. Quick-SOFA score ≥ 2 predicts prolonged hospital stay in geriatric patients with influenza infection. Am J Emerg Med 2020;38(4):780–784. DOI: 10.1016/j.ajem.2019.06.041.
  24. Milić M, Goranović T, Holjevac JK. Correlation of APACHE II and SOFA scores with length of stay in various surgical intensive care units. Coll Antropol 2009;33(3):831–835.
  25. Fowler AA, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA 2019;322(13):1261. DOI: 10.1001/jama.2019.11825.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.